Collections in this community

Recent Submissions

1. Anti-obesity medications or ""medications to treat obesity"" instead of ""weight loss drugs"" - why language matters - an official statement of the Brazilian Association for the Study of Obesity and Metabolic Syndrome (ABESO) and the Brazilian Society of Endocrinology and Metabolism (SBEM)

   ARCHIVES OF ENDOCRINOLOGY METABOLISM, v.67, n.4, article ID e230174, 8p, 2023

   Obesity is largely undertreated, in part because of the stigma surrounding the disease and its treatment. The use of the term ""weight loss drugs"" to refer to medications for the treatment of obesity may contribute to this stigma, leading to the idea that anyone who wants to lose weight could us...

2. Down the rabbit hole: reviewing the evidence for primary prevention of cardiovascular disease in people with obesity

   EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, v.30, n.17, Special Issue, p.1895-1905, 2023

   Obesity is a prevalent chronic disorder and a well-known risk factor for cardiovascular disease. However, the evidence of treating obesity for primary prevention of major cardiovascular events is still scarce and controversial. In this review, we provided a comprehensive description of the curren...

3. The impact of obesity in hospitalized patients with COVID-19: a retrospective cohort study

   DIABETOLOGY & METABOLIC SYNDROME, v.16, n.1, article ID 20, 7p, 2024

   Background Obesity is believed to be a risk factor for COVID-19 and unfavorable outcomes, although data on this remains to be better elucidated.Objective To evaluate the impact of obesity on the endpoints of patients hospitalized due to SARS-CoV-2.Methods This retrospective cohort study evaluated...

4. INCREASED EXPRESSION OF MIR-223-3P AND MIR-375-3P IN HDL TOGETHER WITH A HIGH ANTI-INFLAMMATORY CAPACITY OF HDL IN BREAST CANCER

   ATHEROSCLEROSIS, v.379, suppl.1, p.S61-S61, 2023

5. miRNAs 1915-3p and 4532 as Novel Noninvasive Biomarkers to Detect Renal-Function Decline in Type 1 Diabetes Patients

   DIABETES, v.66, suppl.1, p.LB5-LB6, 2017

6. IMPAIRED HDL-MEDIATED CELL CHOLESTEROL REMOVAL IN ADVANCED BREAST CANCER

   ATHEROSCLEROSIS, v.379, suppl.1, p.S63-S63, 2023

7. Hiperglicemias

   Martins, Herlon Saraiva; Admoni, Sharon Nina; Brandão Neto, Rodrigo Antonio. Hiperglicemias. In: Martins, Herlon Saraiva; Brandão Neto, Rodrigo Antonio; Velasco, Irineu Tadeu (eds). Medicina de emergência: abordagem prática [12.ed.]. BARUERI: Manole, 2017. p.1405-1415.

8. Mindful eating for weight loss in women with obesity: a randomised controlled trial

   BRITISH JOURNAL OF NUTRITION, v.130, n.5, p.911-920, 2023

   Mindful eating (ME) has been linked to improvement in binge eating disorder, but this approach in obesity management has shown conflicting results. Our aim was to assess the effect of ME associated with moderate energy restriction (MER) on weight loss in women with obesity. Metabolic parameters, ...

9. Treatment with Antiobesity Drugs in Weight Regain After Bariatric Surgery: a Retrospective Cohort Study

   OBESITY SURGERY, v.33, n.9, p.2941-2944, 2023

   Background Bariatric surgery is the most efficient treatment for obesity. However, in some cases, weight regain can occur. Currently, it is unknown the best antiobesity medication (AOM) for such clinical situation. This study aims to evaluate the effect of AOM in patients with weight regain after...

10. Fecal microbiota transplantation in patients with metabolic syndrome and obesity: A randomized controlled trial

    WORLD JOURNAL OF CLINICAL CASES, v.11, n.19, p.4612-4624, 2023

    BACKGROUNDMetabolic syndrome is a multifactorial disease, and the gut microbiota may play a role in its pathogenesis. Obesity, especially abdominal obesity, is associated with insulin resistance, often increasing the risk of type two diabetes mellitus, vascular endothelial dysfunction, an abnorma...